No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
LFST LifeStance Health
- 5.290
- +0.050+0.95%
Close Jun 18 16:00 ET
- 5.210
- -0.080-1.51%
Post 17:11 ET
2.02BMarket Cap-11020P/E (TTM)
5.465High5.210Low1.26MVolume5.230Open5.240Pre Close6.73MTurnover1.06%Turnover RatioLossP/E (Static)382.29MShares9.59052wk High1.42P/B631.40MFloat Cap4.73552wk Low--Dividend TTM119.36MShs Float29.811Historical High--Div YieldTTM4.87%Amplitude4.220Historical Low5.337Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
LifeStance Health(LFST.US) Officer Sells US$781.52K in Common Stock
$LifeStance Health(LFST.US)$ Officer Qureshi Danish J. sold 150K shares of common stock on Jun 14, 2024 at an average price of $5.2101 for a total value of $781.52K.Source: Announcement What is statem
Lifestance Health Group Insider Sold Shares Worth $332,143, According to a Recent SEC Filing
Ryan Pardo, Chief Legal Officer and Secretary, on June 12, 2024, sold 61,508 shares in Lifestance Health Group (LFST) for $332,143. Following the Form 4 filing with the SEC, Pardo has control over a t
Form 144 | LifeStance Health(LFST.US) Officer Proposes to Sell 3.19 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 14, $LifeStance Health(LFST.US)$ Officer KHAN DESCENDANTS TRUST LLC intends to sell 589K shares of its common stock on Jun 14, with a total market value of approximately $3
This Insider Has Just Sold Shares In LifeStance Health Group
We'd be surprised if LifeStance Health Group, Inc. (NASDAQ:LFST) shareholders haven't noticed that the President & COO, Danish Qureshi, recently sold US$436k worth of stock at US$5.25 per share. Ho
Lifestance Health Group Insider Sold Shares Worth $470,564, According to a Recent SEC Filing
Kevin Michael Mullins, Chief Development Officer, on June 11, 2024, sold 85,093 shares in Lifestance Health Group (LFST) for $470,564. Following the Form 4 filing with the SEC, Mullins has control ove
J.P. Morgan Maintains LifeStance Health(LFST.US) With Hold Rating, Cuts Target Price to $7
J.P. Morgan analyst Lisa Gill maintains $LifeStance Health(LFST.US)$ with a hold rating, and adjusts the target price from $8 to $7.According to TipRanks data, the analyst has a success rate of 59.5%
Comments
LifeStance Health Group's positive outlook appears to be priced in, but its high growth potential at a fair price makes it an attractive investment. Higher cash flow is expected, potentially leading to a higher share valuation.
Is LifeStance Health Group, Inc. (NASDAQ:LFST) Potentially Undervalued? 1
LifeStance's CEO, Ken Burdick, is confident that Dr. DeLuca's skills will complement the board as they expand mental healthcare access. Dr. DeLuca is excited to join and help more patients receive personalized care.
1
LifeStance Health Group's high P/S ratio reflects market expectations of continued strong revenue growth. Investors may overpay if these expectations aren't met, but strong future revenue forecasts suggest a decrease in revenues is unlikely.
Despite top line growth, LifeStance Health Group is incurring a loss of US$145m on the EBIT line. The company's balance sheet, burdened with liabilities against cash, is deemed unfit and risky.
1
CEO Ken Burdick is confident in Dr. Ramtekkar's ability to drive exceptional patient and clinical outcomes, citing his commitment to clinical excellence. Dr. Ramtekkar is excited to join LifeStance and continue setting the bar for clinical excellence in mental health.
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg